M
Moses R. Kamya
Researcher at Makerere University
Publications - 504
Citations - 15407
Moses R. Kamya is an academic researcher from Makerere University. The author has contributed to research in topics: Malaria & Population. The author has an hindex of 60, co-authored 435 publications receiving 12598 citations. Previous affiliations of Moses R. Kamya include Mulago Hospital.
Papers
More filters
Journal ArticleDOI
Reduced Exposure to Piperaquine, Compared to Adults, in Young Children Receiving Dihydroartemisinin-Piperaquine as Malaria Chemoprevention.
Meghan Whalen,Richard Kajubi,Nona Chamankhah,Liusheng Huang,Francis Orukan,Erika Wallender,Moses R. Kamya,Grant Dorsey,Prasanna Jagannathan,Philip J. Rosenthal,Norah Mwebaza,Francesca T. Aweeka +11 more
TL;DR: In this paper, exposure to DHA and piperaquine in Ugandan children at two ages during infancy was assessed, and it was found that Piperaquine exposure was lower in young children compared with adults, and lower at 104 compared with 32 weeks of age, suggesting a need for age-based DHA-piper aquine dose optimization for chemoprevention.
Journal ArticleDOI
Predicting Malaria in a Highly Endemic Country using Environmental and Clinical Data Sources
TL;DR: The utility of using treatment predictors in conjunction with environmental covariates to predict malaria burden is demonstrated, and the model with the most accurate forecasts varied by site and by forecasting horizon.
Journal ArticleDOI
High viral suppression and low attrition in healthy HIV-infected patients initiated on ART with CD4 above 500 cells/µL in a program setting in Uganda
Dathan M. Byonanebye,Fred C. Semitala,Jackson Katende,Alex Bakenga,Irene Arinaitwe,Peter Kyambadde,Patrick Musinguzi,Irene Andia Biraro,Pauline Byakika-Kibwika,Moses R. Kamya +9 more
TL;DR: Asymptomatic patients initiated on ART with high baseline CD4 counts, achieve high viral suppression with low risk of attrition and VL monitoring and clinic type are associated with viral suppression.
Journal ArticleDOI
Effect of long-lasting insecticidal nets with and without piperonyl butoxide on malaria indicators in Uganda (LLINEUP): final results of a cluster-randomised trial embedded in a national distribution campaign.
Catherine Maiteki-Sebuguzi,Sam Gonahasa,Moses R. Kamya,Agaba Katureebe,Irene Bagala,Amy Lynd,Peter Mutungi,Simon P. Kigozi,Jimmy Opigo,Janet Hemingway,Grant Dorsey,Martin O'Donnell,Sarah G. Staedke +12 more
TL;DR: The LLINEUP trial as discussed by the authors showed that LLINs with piperonyl butoxide (PBO) reduced parasite prevalence more effectively than conventional LLIN (without PBO) for 18 months.
Journal ArticleDOI
Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children.
Erika Wallender,Ali Mohamed Ali,Emma Hughes,Abel Kakuru,Prasanna Jagannathan,Mary K. Muhindo,Bishop Opira,Meghan Whalen,Liusheng Huang,Marvin Duvalsaint,Jenny Legac,Moses R. Kamya,Grant Dorsey,Francesca T. Aweeka,Philip J. Rosenthal,Rada M. Savic +15 more
TL;DR: In this paper, the authors analyzed the effect of dihydroartemisinin-piperaquine (DP) on the protection of children against malaria in a clinical trial in Uganda.